1. Nat Commun. 2022 May 10;13(1):2545. doi: 10.1038/s41467-022-30227-5.

Serum metabolome associated with severity of acute traumatic brain injury.

Thomas I(1), Dickens AM(2)(3), Posti JP(4), Czeiter E(5)(6)(7), Duberg D(8), 
Sinioja T(8), Kråkström M(2), Retel Helmrich IRA(9), Wang KKW(10), Maas AIR(11), 
Steyerberg EW(9)(12), Menon DK(13), Tenovuo O(4), Hyötyläinen T(8), Büki 
A(1)(5)(6), Orešič M(14)(15); CENTER-TBI Participants and Investigators.

Collaborators: Åkerlund C, Amrein K, Andelic N, Andreassen L, Anke A, Antoni A, 
Audibert G, Azouvi P, Azzolini ML, Bartels R, Barzó P, Beauvais R, Beer R, 
Bellander BM, Belli A, Benali H, Berardino M, Beretta L, Blaabjerg M, Bragge P, 
Brazinova A, Brinck V, Brooker J, Brorsson C, Bullinger M, Cabeleira M, 
Caccioppola A, Calappi E, Calvi MR, Cameron P, Lozano GC, Carbonara M, Cavallo 
S, Chevallard G, Chieregato A, Citerio G, Clusmann H, Coburn M, Coles J, Cooper 
JD, Correia M, Čović A, Curry N, Czeiter E, Czosnyka M, Dahyot-Fizelier C, Dark 
P, Dawes H, De Keyser V, Degos V, Corte FD, den Boogert H, Depreitere B, Đilvesi 
Đ, Dixit A, Donoghue E, Dreier J, Dulière GL, Ercole A, Esser P, Ezer E, 
Fabricius M, Feigin VL, Foks K, Frisvold S, Furmanov A, Gagliardo P, Galanaud D, 
Gantner D, Gao G, George P, Ghuysen A, Giga L, Glocker B, Golubovic J, Gomez PA, 
Gratz J, Gravesteijn B, Grossi F, Gruen RL, Gupta D, Haagsma JA, Haitsma I, 
Helbok R, Helseth E, Horton L, Huijben J, Hutchinson PJ, Jacobs B, Jankowski S, 
Jarrett M, Jiang JY, Johnson F, Jones K, Karan M, Kolias AG, Kompanje E, 
Kondziella D, Kornaropoulos E, Koskinen LO, Kovács N, Kowark A, Lagares A, 
Lanyon L, Laureys S, Lecky F, Ledoux D, Lefering R, Legrand V, Lejeune A, Levi 
L, Lightfoot R, Lingsma H, Maas AIR, Castaño-León AM, Maegele M, Majdan M, 
Manara A, Manley G, Martino C, Maréchal H, Mattern J, McMahon C, Melegh B, 
Menovsky T, Mikolic A, Misset B, Muraleedharan V, Murray L, Negru A, Nelson D, 
Newcombe V, Nieboer D, Nyirádi J, Olubukola O, Ortolano F, Palotie A, Parizel 
PM, Payen JF, Perera N, Perlbarg V, Persona P, Peul W, Piippo-Karjalainen A, 
Pirinen M, Ples H, Polinder S, Pomposo I, Posti JP, Puybasset L, Radoi A, 
Ragauskas A, Raj R, Rambadagalla M, Rhodes J, Richardson S, Richter S, Ripatti 
S, Rocka S, Roe C, Roise O, Rosand J, Rosenfeld JV, Rosenlund C, Rosenthal G, 
Rossaint R, Rossi S, Rueckert D, Rusnák M, Sahuquillo J, Sakowitz O, 
Sanchez-Porras R, Sandor J, Schäfer N, Schmidt S, Schoechl H, Schoonman G, Schou 
RF, Schwendenwein E, Sewalt C, Skandsen T, Smielewski P, Sorinola A, Stamatakis 
E, Stanworth S, Stevens R, Stewart W, Stocchetti N, Sundström N, Takala R, Tamás 
V, Tamosuitis T, Taylor MS, Te Ao B, Theadom A, Thomas M, Tibboel D, Timmers M, 
Tolias C, Trapani T, Tudora CM, Unterberg A, Vajkoczy P, Vallance S, Valeinis E, 
Vámos Z, van der Jagt M, Van der Steen G, van der Naalt J, van Dijck JTJM, van 
Essen TA, Van Hecke W, van Heugten C, Van Praag D, Vyvere TV, van Wijk RPJ, 
Vargiolu A, Vega E, Velt K, Verheyden J, Vespa PM, Vik A, Vilcinis R, Volovici 
V, von Steinbüchel N, Voormolen D, Vulekovic P, Wiegers E, Williams G, Wilson L, 
Winzeck S, Wolf S, Yang Z, Ylén P, Younsi A, Zeiler FA, Zelinkova V, Ziverte A, 
Zoerle T.

Author information:
(1)School of Medical Sciences, Örebro University, Örebro, Sweden.
(2)Turku Bioscience Centre, University of Turku and Åbo Akademi University, 
Turku, Finland.
(3)Department of Chemistry, University of Turku, Turku, Finland.
(4)Neurocenter, Department of Neurosurgery and Turku Brain Injury Center, Turku 
University Hospital and University of Turku, Turku, Finland.
(5)Department of Neurosurgery, Medical School, University of Pécs, Pécs, 
Hungary.
(6)Neurotrauma Research Group, Szentágothai Research Centre, University of Pécs, 
Pécs, Hungary.
(7)MTA-PTE Clinical Neuroscience MR Research Group, Pécs, Hungary.
(8)Department of Chemistry, Örebro University, Örebro, Sweden.
(9)Department of Public Health, Center for Medical Decision Making, Erasmus 
MC-University Medical Center, Rotterdam, The Netherlands.
(10)Program for Neurotrauma, Neuroproteomics & Biomarkers Research, Department 
of Emergency Medicine, McKnight Brin Institute of the University of Florida, 
Gainesville, Florida, USA.
(11)Department of Neurosurgery, Antwerp University Hospital and University of 
Antwerp, Edegem, Belgium.
(12)Department of Biomedical Data Sciences, Leiden University Medical Center, 
Leiden, The Netherlands.
(13)Division of Anaesthesia, University of Cambridge, Addenbrooke's Hospital, 
Cambridge, UK.
(14)School of Medical Sciences, Örebro University, Örebro, Sweden. 
matej.oresic@oru.se.
(15)Turku Bioscience Centre, University of Turku and Åbo Akademi University, 
Turku, Finland. matej.oresic@oru.se.

Complex metabolic disruption is a crucial aspect of the pathophysiology of 
traumatic brain injury (TBI). Associations between this and systemic metabolism 
and their potential prognostic value are poorly understood. Here, we aimed to 
describe the serum metabolome (including lipidome) associated with acute TBI 
within 24 h post-injury, and its relationship to severity of injury and patient 
outcome. We performed a comprehensive metabolomics study in a cohort of 716 
patients with TBI and non-TBI reference patients (orthopedic, internal medicine, 
and other neurological patients) from the Collaborative European NeuroTrauma 
Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) cohort. We 
identified panels of metabolites specifically associated with TBI severity and 
patient outcomes. Choline phospholipids (lysophosphatidylcholines, ether 
phosphatidylcholines and sphingomyelins) were inversely associated with TBI 
severity and were among the strongest predictors of TBI patient outcomes, which 
was further confirmed in a separate validation dataset of 558 patients. The 
observed metabolic patterns may reflect different pathophysiological mechanisms, 
including protective changes of systemic lipid metabolism aiming to maintain 
lipid homeostasis in the brain.

© 2022. The Author(s).

DOI: 10.1038/s41467-022-30227-5
PMCID: PMC9090763
PMID: 35538079 [Indexed for MEDLINE]

Conflict of interest statement: The authors declare no competing interests.